Seer, Inc. - Current Ratio

The Current Ratio as of June 2026 (TTM) for Seer, Inc. (SEER) is 17.73

According to Seer, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 17.73. This represents a change of 10.86% compared to the average of 15.99 of the last 4 quarters.

Seer, Inc. (SEER) Historical Current Ratio (quarterly & annually)

How has SEER Current Ratio performed in the past?

The mean historical Current Ratio of Seer, Inc. over the last ten years is 25.54. The current 17.73 Current Ratio has changed 6.84% with respect to the historical average. Over the past ten years (40 quarters), SEER's Current Ratio was at its highest in in the March 2021 quarter at 72.50. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Seer, Inc. (SEER) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Seer, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Seer, Inc. (SEER) Average Current Ratio

How has SEER Current Ratio performed in the past?

The current Current Ratio of Seer, Inc. (SEER) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Seer, Inc. (SEER) Current Ratio vs. Peers

How is SEER’s Current Ratio compared to its peers?

Seer, Inc.’s Current Ratio is greater than ORIC Pharmaceuticals, Inc. (16.33), greater than Anebulo Pharmaceuticals, Inc. (16.71), greater than Cullinan Therapeutics, Inc. (10.28), greater than C4 Therapeutics, Inc. (9.00), greater than Molecular Partners AG (9.42), less than Mineralys Therapeutics, Inc. (44.33), greater than AN2 Therapeutics, Inc. (15.73), greater than Pharvaris N.V. (11.24), greater than PepGen Inc. (14.98), greater than Foghorn Therapeutics Inc. (2.92), less than Shattuck Labs, Inc. (22.06), greater than Monte Rosa Therapeutics, Inc. (9.54), greater than Kymera Therapeutics, Inc. (10.81), greater than Nurix Therapeutics, Inc. (6.01), greater than Quantum-Si incorporated (12.60), greater than HCW Biologics Inc. (0.09), greater than MediciNova, Inc. (9.09), greater than Nkarta, Inc. (12.96), greater than Lyell Immunopharma, Inc. (7.23), greater than Generation Bio Co. (4.44), greater than Sana Biotechnology, Inc. (1.29),

Build a custom stock screener for Seer, Inc. (SEER) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Seer, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Seer, Inc. (SEER) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Seer, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.